KBI Biopharma Email Format

Biotechnology Research
1,001-2,500 employees
Durham, NC, USA

KBI Biopharma is a contract development and manufacturing organization providing integrated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.

Find contacts at KBI Biopharma

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstinitiallast@kbibiopharma.com

Company Overview

Industry
Biotechnology Research
Founded
1996
Headquarters
Durham, NC, USA
Revenue
$500M-$1B
FUNDING Stage
Subsidiary
Key Executives
Tim Lowery (Chief Executive Officer), Katherine Wolf (Chief Financial Officer), Peter Carbone (Chief Operating Officer)

Tech Stack

HubSpot

Marketing

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of KBI Biopharma?

KBI Biopharma uses the firstinitiallast format, so Jane Smith would be jsmith@kbibiopharma.com.

What core services does KBI Biopharma offer as a CDMO?

KBI Biopharma provides end-to-end contract development and manufacturing services including cell line development, process development, analytical testing, and GMP manufacturing for biologics across mammalian and microbial platforms.

Where are KBI Biopharma's facilities located?

KBI Biopharma operates facilities in Durham, Research Triangle Park, and Patriot Park in North Carolina, as well as Boulder and Louisville in Colorado, and Geneva, Switzerland.

How can I find the right KBI Biopharma contact for a biologics development partnership?

You can reach KBI Biopharma directly at info@kbibiopharma.com, or use a tool like Clay to enrich and verify specific contact details for KBI Biopharma's business development or scientific teams before outreach.

Which proprietary technology platform does KBI Biopharma use for CHO-based cell line development?

KBI Biopharma developed the SUREtechnology Platform, a CHO-based cell line development system that includes the SURE CHO-M Cell Line and SUREmAb tools for accelerating biologics drug development programs.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles